Something that may delay any announcement and ultimately FDA approval, will be availability of "product". I understand our manufacturing partner is cranking up production, but it will take time before there is sufficient stock available to meet demand if FDA approved. If we have very good results, everyone with this bug in the USA will expect immediate access to RYONCIL (supported by families, pollies, medical professionals etc). I know MSB has an obligation to keep the market informed, but in this instance I would not be surprised if there are delays in "confirmation" of results and FDA approval until enough stock is available - or at least enough to meet the requirements of USA.
MSB Trading - 2020, page-19519
-
- There are more pages in this discussion • 3,642 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.015(1.29%) |
Mkt cap ! $1.347B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.20 | $1.15 | $4.551M | 3.886M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 98246 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 19079 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |